When Cholesterol Drugs Cost $14,000, an Insurance Tug-of-War

Patients struggle to obtain PCSK9 inhibitors, a powerful class of drugs that lower bad cholesterol in difficult cases and when usual treatments and statins don’t work.

from WSJ.com: Lifestyle http://ift.tt/2sJKFJS
via LIFESTYLE